Rare Disease Breakthroughs and Biotech Frontiers
Kilder
- biopharmadive.com: Travere wins long-awaited approval for kidney disease drug - BioPharma Dive
- biospace.com: Travere’s Filspari overcomes Phase 3 fail to become first drug for rare kidney disease - BioSpace
- bioworld.com: Travere’s Filspari approved for rare kidney disease FSGS - BioWorld News
- Statnews: My brother can’t access a just-approved breakthrough drug for his rare disease - statnews.com
- statnews.com: My brother can’t access a just-approved breakthrough drug for his rare disease - statnews.com
- raps.org: Recon: FDA narrows search for new CBER director; Novo enters drug discovery pact with OpenAI - RAPS.org
- biospace.com: FDA bolsters bespoke therapy framework with new draft safety guidelines - BioSpace
- bioworld.com: New guidance advises on assessing safety of gene editing - BioWorld News
- Nature: Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy - Nature
- nature.com: Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy - Nature
- Bioworld: Senescent tumor-derived nanovesicles restore antitumor immunity - BioWorld News
- bioworld.com: Senescent tumor-derived nanovesicles restore antitumor immunity - BioWorld News
- genengnews.com: AWS Launches Amazon Bio Discovery Agentic AI to Accelerate Drug Development - Genetic Engineering and Biotechnology News
- bioworld.com: More of everything as Amazon moves into AI-driven drug R&D - BioWorld News
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.